celecoxib has been researched along with Meningioma in 3 studies
Meningioma: A relatively common neoplasm of the CENTRAL NERVOUS SYSTEM that arises from arachnoidal cells. The majority are well differentiated vascular tumors which grow slowly and have a low potential to be invasive, although malignant subtypes occur. Meningiomas have a predilection to arise from the parasagittal region, cerebral convexity, sphenoidal ridge, olfactory groove, and SPINAL CANAL. (From DeVita et al., Cancer: Principles and Practice of Oncology, 5th ed, pp2056-7)
| Excerpt | Relevance | Reference |
|---|---|---|
| "Our findings suggest that celecoxib may not be effective on meningioma growth in clinical settings." | 7.79 | Effect of systemic celecoxib on human meningioma after intracranial transplantation into nude mice. ( Friedrich, S; Grote, M; Krauss, JK; Nakamura, M; Schwabe, K, 2013) |
| "Meningioma cell lines (IOMM-Lee, CH157-MN, WHO grade I primary cultured tumor) were transplanted into flanks of nude mice fed mouse chow with celecoxib at varying concentrations (0, 500, 1000, 1500 ppm) ad libitum." | 7.74 | Celecoxib inhibits meningioma tumor growth in a mouse xenograft model. ( Couldwell, WT; Gillespie, DL; Jensen, RL; Prescott, SM; Ragel, BT, 2007) |
| "Meningiomas are the second most common symptomatic primary central nervous system tumor in adults." | 5.33 | Ubiquitous expression of cyclooxygenase-2 in meningiomas and decrease in cell growth following in vitro treatment with the inhibitor celecoxib: potential therapeutic application. ( Couldwell, WT; Gillespie, DL; Jensen, RL; Prescott, SM; Ragel, BT, 2005) |
| "Our findings suggest that celecoxib may not be effective on meningioma growth in clinical settings." | 3.79 | Effect of systemic celecoxib on human meningioma after intracranial transplantation into nude mice. ( Friedrich, S; Grote, M; Krauss, JK; Nakamura, M; Schwabe, K, 2013) |
| "Meningioma cell lines (IOMM-Lee, CH157-MN, WHO grade I primary cultured tumor) were transplanted into flanks of nude mice fed mouse chow with celecoxib at varying concentrations (0, 500, 1000, 1500 ppm) ad libitum." | 3.74 | Celecoxib inhibits meningioma tumor growth in a mouse xenograft model. ( Couldwell, WT; Gillespie, DL; Jensen, RL; Prescott, SM; Ragel, BT, 2007) |
| "Meningiomas are the second most common symptomatic primary central nervous system tumor in adults." | 1.33 | Ubiquitous expression of cyclooxygenase-2 in meningiomas and decrease in cell growth following in vitro treatment with the inhibitor celecoxib: potential therapeutic application. ( Couldwell, WT; Gillespie, DL; Jensen, RL; Prescott, SM; Ragel, BT, 2005) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (66.67) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Friedrich, S | 1 |
| Schwabe, K | 1 |
| Grote, M | 1 |
| Krauss, JK | 1 |
| Nakamura, M | 1 |
| Ragel, BT | 2 |
| Jensen, RL | 2 |
| Gillespie, DL | 2 |
| Prescott, SM | 2 |
| Couldwell, WT | 2 |
3 other studies available for celecoxib and Meningioma
| Article | Year |
|---|---|
Effect of systemic celecoxib on human meningioma after intracranial transplantation into nude mice.
Topics: Aged; Aged, 80 and over; Animals; Brain Neoplasms; Celecoxib; Cell Culture Techniques; Cell Survival | 2013 |
Ubiquitous expression of cyclooxygenase-2 in meningiomas and decrease in cell growth following in vitro treatment with the inhibitor celecoxib: potential therapeutic application.
Topics: Adult; Aged; Aged, 80 and over; Apoptosis; Blotting, Western; Celecoxib; Cell Proliferation; Cycloox | 2005 |
Celecoxib inhibits meningioma tumor growth in a mouse xenograft model.
Topics: Animals; Apoptosis; Celecoxib; Cyclooxygenase 2; Cyclooxygenase Inhibitors; Factor VIII; Humans; Imm | 2007 |